Metraipolis › archive › dc_7bc751387b47

Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook — Europe PMC PMID:42175671

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42175671
DOI
10.1002/ctm2.70702
License (as archived)
solo-consultazione
Archived
2026-11-02T19:48:40.115Z
SHA-256 of the archived text
c456456a5754d53b5ffdb12bc824e8274171a2f08b33f33167e42a48d9b2b083
Stable URL of this page
https://metraipolis.com/documento/dc_7bc751387b47

How to cite

Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook — Europe PMC PMID:42175671 — Europe PMC (en), https://europepmc.org/article/MED/42175671 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bc751387b47 (Metraipolis archive dc_7bc751387b47, sha256 c456456a5754d53b5ffdb12bc824e8274171a2f08b33f33167e42a48d9b2b083)
BibTeX
@misc{dc7bc751387b47,
  title = {Integrating oncolytic adenoviruses into combination cancer therapy: Mechanisms, advances and clinical outlook — Europe PMC PMID:42175671},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42175671},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bc751387b47; sha256 c456456a5754d53b5ffdb12bc824e8274171a2f08b33f33167e42a48d9b2b083},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42175671. Agents can read the archived copy with the MCP tool read_document.